Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Comment

被引：0

作者：

Grogger, J ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Publ Policy, Los Angeles, CA 90024 USA

来源：

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION | 2001年 / 96卷 / 456期

关键词：

D O I：

暂无

中图分类号：

O21 [概率论与数理统计]; C8 [统计学];

学科分类号：

020208 ; 070103 ; 0714 ;

摘要：

引用

页码：1268 / 1269

页数：2

共 29 条

[1] Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Rejoinder
Horowitz, JL
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2001, 96 (456) : 1269 - 1271
[2] Should the DEAs STRIDE data be used for economic analyses of markets for illegal Drugs?
Fries, A
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2002, 97 (458) : 660 - 660
[3] Putting a price on drugs: An economic sociological study of price formation in illegal drug markets
Moeller, Kim
Sandberg, Sveinung
CRIMINOLOGY, 2019, 57 (02) : 289 - 313
[4] The potential for accurately measuring behavioral and economic dimensions of consumption, prices, and markets for illegal drugs
Johnson, Bruce D.
Golub, Andrew
DRUG AND ALCOHOL DEPENDENCE, 2007, 90 : S16 - S26
[5] SHOULD CONTROL-THEORY BE USED FOR ECONOMIC-STABILIZATION - COMMENT
BRYANT, J
CARNEGIE-ROCHESTER CONFERENCE SERIES ON PUBLIC POLICY, 1977, 7 : 99 - 100
[6] SHOULD CONTROL-THEORY BE USED FOR ECONOMIC-STABILIZATION - COMMENT
MODIGLIANI, F
CARNEGIE-ROCHESTER CONFERENCE SERIES ON PUBLIC POLICY, 1977, 7 : 85 - 91
[7] Evaluation of conflict of interest in economic analyses of new drugs used in oncology
Friedberg, M
Saffran, B
Stinson, TJ
Nelson, W
Bennett, CL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15): : 1453 - 1457
[8] Economic(s) matters: Should regulation try to replicate competitive markets?
Sundakov, Alex
AUSTRALIAN JOURNAL OF COMPETITION AND CONSUMER LAW, 2013, 21 (02):
[9] SHOULD THE KRAMERS-KRONIG TRANSFORMS BE USED FOR THE VALIDATION OF EXPERIMENTAL IMPEDANCE DATA - COMMENT
MACDONALD, DD
URQUIDIMACDONALD, M
CORROSION, 1989, 45 (04) : 327 - 328
[10] Should new drugs be used without outcome data? Implications of ALLHAT and ELITE II
Kaplan, NM
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (04) : 511 - 512

← 1 2 3 →